Author

E. V. Leblanc

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. C. Colpitts· 2 shared C. J. Capicciotti· 1 shared J. L. Babulic· 1 shared J. M. Kofsky· 1 shared M. E. Boddington· 1 shared S. Emberley-Korkmaz· 1 shared Y. Kim· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C. C. Colpitts

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

One-Step Selective Labeling of Native Cell-Surface Sialoglycans by Exogenous α2,8-Sialylation

J. L. Babulic, J. M. Kofsky, M. E. Boddington, Y. Kim, E. V. Leblanc, S. Emberley-Korkmaz, C. C. Colpitts, C. J. Capicciotti

This paper identifies a sialyltransferase for selectively labeling native cell-surface sialoglycans with 2,8-disialyl epitopes using exogenous CMP-Neu5Ac derivatives.

bioRxiv · Aug 1, 2023Biochemistry

The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus entry inhibitor

E. V. LeBlanc, C. C. Colpitts

This study shows that EGCG inhibits coronavirus entry by blocking attachment, suggesting it could be a broad-spectrum antiviral against current and future coronaviruses.

bioRxiv · Jun 21, 2021 · PreprintMicrobiology